The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-γ (PPARγ) Activation and Rho-associated Kinase (ROCK) Inhibition.

The Journal of Biological Chemistry
Nasim-Sadat KajabadiHossein Baharvand

Abstract

Although human pluripotent stem cells (hPSCs) provide valuable sources for regenerative medicine, their applicability is dependent on obtaining both suitable up-scaled and cost effective cultures. The Rho-associated kinase (ROCK) inhibitor Y-27632 permits hPSC survival upon dissociation; however, cloning efficiency is often still low. Here we have shown that pioglitazone, a selective peroxisome proliferative-activated receptor-γ agonist, along with Y-27632 synergistically diminished dissociation-induced apoptosis and increased cloning efficiency (2-3-fold versus Y-27632) without affecting pluripotency of hPSCs. Pioglitazone exerted its positive effect by inhibition of glycogen synthase kinase (GSK3) activity and enhancement of membranous β-catenin and E-cadherin proteins. These effects were reversed by GW-9662, an irreversible peroxisome proliferative-activated receptor-γ antagonist. This novel setting provided a step toward hPSC manipulation and its biomedical applications.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Dec 26, 2001·Chemical Reviews·A AliJ R Woodgett
Mar 14, 2002·Biochemical and Biophysical Research Communications·Cornelia DietrichFranz Oesch
Nov 3, 2004·Growth Factors·Céline PrunierPhilip H Howe
Nov 12, 2005·Stem Cells·Mark E LevensteinJames A Thomson
Mar 4, 2006·Development, Growth & Differentiation·Hossein BaharvandAli Farrokhi
Jan 2, 2007·Biochemical and Biophysical Research Communications·Yukinari TakaoHiroshi Koide
May 24, 2007·Pflügers Archiv : European journal of physiology·Yuntao S Mao, Helen L Yin
May 29, 2007·Nature Biotechnology·Kiichi WatanabeYoshiki Sasai
Mar 6, 2009·American Journal of Physiology. Cell Physiology·Kevin B AtkinsFrank C Brosius
Oct 31, 2009·The International Journal of Developmental Biology·Mehdi TotonchiHossein Baharvand
Jun 8, 2012·Sub-cellular Biochemistry·Oda Hiroki
Jan 1, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jason GienSteven H Abman

❮ Previous
Next ❯

Citations

Nov 8, 2017·Cellular and Molecular Neurobiology·Neda MazaheriMohammad Hossein Nasr-Esfahani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis